These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22806266)

  • 1. Applying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin delivery.
    González-Rodríguez ML; Mouram I; Cózar-Bernal MJ; Villasmil S; Rabasco AM
    J Pharm Sci; 2012 Oct; 101(10):3845-63. PubMed ID: 22806266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
    Bendas ER; Abdullah H; El-Komy MH; Kassem MA
    Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positively and negatively charged liposomes as carriers for transdermal delivery of sumatriptan: in vitro characterization.
    Villasmil-Sánchez S; Drhimeur W; Ospino SC; Rabasco Alvarez AM; González-Rodríguez ML
    Drug Dev Ind Pharm; 2010 Jun; 36(6):666-75. PubMed ID: 20136486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
    Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
    Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery.
    Gupta M; Vaidya B; Mishra N; Vyas SP
    Artif Cells Blood Substit Immobil Biotechnol; 2011 Dec; 39(6):376-84. PubMed ID: 21951195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
    Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
    Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of formulation compositions on niosomal preparations.
    Chaw CS; Kim KY
    Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M; Sammour OA; Hammad MA; Megrab NA
    Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
    Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
    Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
    Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
    Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
    Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
    Pardakhty A; Varshosaz J; Rouholamini A
    Int J Pharm; 2007 Jan; 328(2):130-41. PubMed ID: 16997517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine.
    Shaikh KS; Chellampillai B; Pawar AP
    Drug Dev Ind Pharm; 2010 Aug; 36(8):946-53. PubMed ID: 20196642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and skin permeation of ketoprofen-loaded vesicular systems.
    Uchino T; Lefeber F; Gooris G; Bouwstra J
    Eur J Pharm Biopharm; 2014 Feb; 86(2):156-66. PubMed ID: 23500115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of methotrexate loaded niosomes by Box-Behnken design: an understanding of solvent effect and formulation variability.
    Zidan AS; Mokhtar Ibrahim M; Megrab NAE
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1450-1459. PubMed ID: 28420295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
    Hasan AA
    Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
    Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium dodecyl sulfate improved stability and transdermal delivery of salidroside-encapsulated niosomes via effects on zeta potential.
    Zhang Y; Jing Q; Hu H; He Z; Wu T; Guo T; Feng N
    Int J Pharm; 2020 Apr; 580():119183. PubMed ID: 32112930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a high performance chromatographic method for determining sumatriptan in niosomes.
    Cózar-Bernal MJ; Rabasco AM; González-Rodríguez ML
    J Pharm Biomed Anal; 2013 Jan; 72():251-60. PubMed ID: 23063308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.